Summary
Background
Gene targeting using short interfering RNA(siRNA) has become a common strategy to explore gene function because of its prominent efficacy and specificity. It is proven that the application of siRNA technology to gene therapy is effective. In this study, we constructed a siRNA expression plasmid against gene X-linked inhibitor of apoptosis (XIAP), and then used breast cancer cells MCF-7 to assess its functions.
Materials and methods
XIAP siRNA plasmid was constructed using an U6pro vector contained U6 promoter, After the plasmid had been transfected into MCF-7 cells and effected on the cell cycle, the expression change of XIAP was examined by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) and Western blot. The apoptosis of the transfected cells was analyzed by flow cytometry, and TUNEL method. The in vitro cellular growth activities were assayed by MTT incorporation. Twenty-four nude mice were randomly divided into 3 equal groups and were inoculated with electroinjection of blank plasmid, scrambled nucleotide control (control siRNA), or siRNA against XIAP subcutaneously respectively, then the appearance and size of tumors were observed. Four weeks later the mice were killed and the volumes of tumor were calculated so as to evaluate the therapeutic effects of siRNA against XIAP.
Results
The successful construction of siRNA against XIAP plasmid was identified with sequencing. After the siRNA expression vector was transfected into the MCF-7 cells, the expression of XIAP gene was inhibited significantly (by 90%). The cellular growth activities in the MCF-7 cells transfected with siRNA against XIAP plasmid decreased obviously. The siRNA against XIAP plasmid knocked down XIAP expression in MCF-7 cells obviously, arrested the cell cycle in G1 phase, inhibited cell proliferation significantly, and promoted cell apoptosis in a tendency. TUNEL assay and flow cytometry showed that the classic apoptosis characters of the MCF-7 cells transfected with siRNA against XIAP plasmid manifested an apoptosis rate of 77.2%, significantly higher than those in the control siRNA group and in the blank plasmid group (both p < 0.01). The growth speed and formation rate of xenograft tumor in mice transfected with siRNA against XIAP transfected mice slowed down significantly. By HE staining, a lot of necrotic tissues could be observed in the siRNA against XIAP transfected group, however, there was no similar inhibitive effect in the control siRNA or blank plasmid group.
Conclusion
This study represents that MCF-7 transfected cells with siRNA against XIAP remarkably suppress tumor growth and induces apoptosis, both in vitro and in vivo. This novel modality may be a promising tool for cancer therapy.
Similar content being viewed by others
References
WHO, World Health Report 2003. World Health Organization, Geneva, 2003
Sharp PA RNA interference-2001 Genes Dev 2001, 15:485–490
Hutvagner G, Zamore PD RNAi: nature abhors a double-strand Curr Opin Genet Dev 2002, 12:225–232
Hannon GJ, Rossi JJ Unlocking the potential of the human genome with RNA interference Nature 2004, 431:371–8
Bernstein E, Caudy AA, Hammond SM, Hannon GJ: Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409: 363–366, 2001
Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ Argonaute2, a link between genetic and biochemical analyses of RNAi Science 2001, 293:1146–1150
Manche L, Green SR, Schmedt C, Mathews MBInteractions between double-stranded RNA regulators and the protein kinase DAI Mol Cell Biol. 1992, 11:5238–5248
Lowe SW, Lin AW Apoptosis in cancer Carcinogenesis 2000, 21:485–495
Thompson CB Apoptosis in the pathogenesis and treatment of disease Science 1995, 267:1456–1462
Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS, Reed JC: A single BIR domain of XIAP sufficient for inhibiting caspases J Biol Chem 1998, 273:7787–7790
Choi YJ, Kim TG, Kim YH, Lee SH, Kwon YK, Suh SI, Park JW, Kwon TK Immunosuppressant PG490 (triptolide) induces apoptosis through the activation of caspase-3 and down-regulation of XIAP in U937 cells Biochem Pharmacol 2003, 66:273–280
Shiozaki EN, Chai J, Rigotti DJ, Riedl SJ, Li P, Srinivasula SM, Alnemri ES, Fairman R, Shi Y Mechanism of XIAP-mediated inhibition of caspase-9 Mol Cell 2003, 11:519–527
Zou H, Yang R, Hao J, Wang J, Sun C, Fesik SW, Wu JC, Tomaselli KJ, Armstrong RC Regulation of the Apaf-1/caspase-9 apoptosome by caspase-3 and XIAP J Biol Chem 2003, 278:8091–8098
Sasaki H, Sheng Y, Kotsuji F, Tsang BK Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells Cancer Res 2000, 60:5659–5666
Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PNThe protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase Cell 1995, 81:727–736
Burgering BM, Coffer PJ Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction Nature 1995, 376:599–602
Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785–789
Bellacosa A, Testa JR, Staal SP, Tsichlis PN A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region Science 1991, 254:274–277
Cheng JQ, Godwin AK, Belacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN, Testa JR: AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas Proc Natl Acad Sci USA 1992, 89:9267–9271
Nakatani K, Sakaue H, Thompson DA, Weigel RJ, Roth RA Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site Biochem Biophys Res Commun 1999, 257:906–10
Datta SR, Brunet A, Greenberg ME Cellular survival: a play in three Akts Genes Dev 1999, 13:2905–2927
Deveraux QL, Reed JC IAP family proteins–suppressors of apoptosis Genes Dev 1999, 13:239–252
Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, Korneluk RG Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes Nature 1996, 379:349–353
Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases EMBO J 1998, 17:2215–2223
Ping Hu, Zhang Han, Anthony D, Couvillon John H Critical role of endogenous Akt/IAPs and MEK1/EPK pathways in counteracting endoplasmic reticulum stress-induced cell death J Biol Chem 2004, 279:49420–49429
Dykxhoorn DM, Novina CD, Sharp PA Killing the messenger: short RNAs that silence gene expression Nat Rev Mol Cell Biol 2003, 4:457–467
Uchida H, Shinoura N, Kitayama J, Watanabe T, Nagawa H, Hamada H 5-Fluorouracil efficiently enhanced apoptosis induced by adenovirus-mediated transfer of caspase-8 in DLD-1 colon cancer cells J Gene Med 2003, 5:287–299
Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs Cancer Res 1998, 58:5315–5320
Ambrosini G, Adida C, Altieri DC A novel anti-apoptosis gene, surviving, expressed in cancer and lymphoma Nat Med 1997, 3:917–921
Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation Am J Pathol 1998, 152:43–49
Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, Farahani R, McLean M, Ikeda JE, MacKenzie A, Korneluk RG Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes Nature 1996, 379:349–353
Sasaki H, Li J, Schneiderman D, et al.: Life, death, and immortality: cellular and molecular perspectives in human breast cancer cell growth Front Endocrin 1999, 21:349–358
Green DR., Reed JC: Mitochondria and apoptosis Science 1998, 281:1309–1312
(a) Dragovich T, Rudin CM, Thompson CB: Signal transduction pathways that regulate cell survival and cell death. Oncogene 1998, 17: 3207–3213, 1998; (b) Nunez G, Benedict MA, Hu Y, Inohara N: Caspases: the proteases of the apoptotic pathway. Oncogene 17: 3237–3245, 1998; (c) LaCasse EC, Baird S, Korneluk RG, MacKenzie AE: The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17: 3247–3259, 1998
Levine EL, Renehan A, Gossiel R, Davidson SE, Roberts SA, Chadwick C, Wilks DP, Potten CS, Hendry JH, Hunter RD, et al.: Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma Radiother Oncol 1995, 37:1–9
Bowen ID, Bowen SM: Programmed Cell Death in Tumors and Tissues. Chapman Hall, London, 1990
Wenzel AN, Grimm Ch, Samardzija MA, et al.: Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotein for retinal degeneration Prog Ret Eye Res 2005, 24:275–306
Bergers G, Benjamin LE Tmorigenesis and angiogenic swith Nat Res Cancer 2003, 3:401–410
Sun C, Cai M, Meadows RP, Xu N, Gunasekera AH, Herrmann J, Wu JC, Fesik SW NMR structure, mutagenesis of the third Bir domain of the inhibitor of apoptosis protein XIAP J Biol Chem 2000, 275:33777–33781
Srinivasula SM, Hegde R, Saleh A, et al.: A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis Nature 2001, 410:112–116
Shiozaki EN, Chai J, Rigotti DJ, et al.: Mechanism of XIAP-mediated inhibition of caspase-9 Mol Cell 2003, 11:519–527
Lima RT, Martins LM, Guimaraes JE, Sambade C, Vasconcelos MH Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells Cancer Gene Ther 2004, 11:309–316
Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate EMBO J 2001, 20:6877–6888
Tuschl T, Zamore PD, Lehmann R, Bartel DP, Sharp PA Targeted mRNA degradation by double-stranded RNA in vitro Genes Dev 1999, 13:3191–3197
Hutvagner G, Zamore PD: A microRNA in a multiple-turnover RNAi enzyme complex. Science 297: 2056–2060, 2002
Semizarov D, Frost L, Sarthy A, Kroeger P, Halbert DN, Fesik SW Specificity of short interfering RNA determined through gene expression signatures Proc Natl Acad Sci USA 2003, 100:6347–6352
Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS Expression profiling reveals off-target gene regulation by RNAi Nat Biotechnol 2003, 21:635–637
Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC Regulation of cell death protease caspase-9 by phosphorylation Science 1998, 282:1318–1321
Author information
Authors and Affiliations
Corresponding author
Additional information
Address for offprints and correspondence: Wang Yu, Department of Surgery, The Second Hospital of Jilin University, 218 Ziqiang Street, Changchun 130041, PR China; Tel./fax: +86-431-7819063, E-mail: wangyu720529@yahoo.com
An erratum to this article can be found at http://dx.doi.org/10.1007/s10549-007-9513-z
Rights and permissions
About this article
Cite this article
Zhang, Y., Wang, Y., Gao, W. et al. Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo . Breast Cancer Res Treat 96, 267–277 (2006). https://doi.org/10.1007/s10549-005-9080-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-9080-0